Acurx Pharmaceuticals
ACXP
ACXP
22 hedge funds and large institutions have $2.41M invested in Acurx Pharmaceuticals in 2024 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 5 increasing their positions, 6 reducing their positions, and 4 closing their positions.
Holders
22
Holders Change
-3
Holders Change %
-12%
% of All Funds
0.32%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
5
Reduced
6
Closed
4
Calls
$17K
Puts
$25K
Net Calls
-$8K
Net Calls Change
-$30K
Top Buyers
| 1 |
1
Vanguard Group
Malvern,
Pennsylvania
|
$1.01M |
| 2 |
SG
2
StoneX Group
New York
|
$33.8K |
| 3 |
PFS
3
Prospect Financial Services
Melville,
New York
|
$561K |
| 4 |
4
Geode Capital Management
Boston,
Massachusetts
|
$278K |
| 5 |
5
BlackRock
New York
|
$54.2K |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
26
Citadel Advisors
Miami,
Florida
| – | – | -64 | Closed |
|
|
CFGS
27
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|